10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2009 | |||
Consolidated Statement Of Earnings | |||
Period Ending Dec 31, 2009 10-K (Filed: Feb 19, 2010) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| EARNINGS | |||
| Net Sales | $ 18,808 | 17,715 | 15,617 |
| Cost of products sold | 5,140 | 5,316 | 4,919 |
| Marketing, selling and administrative | 3,946 | 4,140 | 3,941 |
| Advertising and product promotion | 1,136 | 1,181 | 1,097 |
| Research and development | 3,647 | 3,512 | 3,160 |
| Acquired in-process research and development | 0 | 32 | 230 |
| Provision for restructuring | 136 | 215 | 180 |
| Litigation expense | 132 | 33 | 14 |
| Equity in net income of affiliates | (550) | (617) | (524) |
| Gain on sale of ImClone shares | 0 | (895) | 0 |
| Other (income)/expense | (381) | 22 | 77 |
| Total Expenses | 13,206 | 12,939 | 13,094 |
| Earnings from Continuing Operations Before Income Taxes | 5,602 | 4,776 | 2,523 |
| Provision for income taxes | 1,182 | 1,090 | 471 |
| Net Earnings from Continuing Operations | 4,420 | 3,686 | 2,052 |
| Discontinued Operations: | |||
| Earnings, net of taxes | 285 | 578 | 876 |
| Gain on disposal, net of taxes | 7,157 | 1,979 | 0 |
| Net Earnings from Discontinued Operations | 7,442 | 2,557 | 876 |
| Net Earnings | 11,862 | 6,243 | 2,928 |
| Net Earnings Attributable to Noncontrolling Interest | 1,250 | 996 | 763 |
| Net Earnings Attributable to Bristol-Myers Squibb Company | 10,612 | 5,247 | 2,165 |
| Amounts Attributable to Bristol-Myers Squibb Company: | |||
| Net Earnings from Continuing Operations | 3,239 | 2,697 | 1,296 |
| Net Earnings from Discontinued Operations | 7,373 | 2,550 | 869 |
| Net Earnings Attributable to Bristol-Myers Squibb Company | 10,612 | 5,247 | 2,165 |
| Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company: | |||
| Basic | 1.63 | 1.36 | 0.65 |
| Diluted | 1.63 | 1.35 | 0.65 |
| Earnings per Common Share Attributable to Bristol-Myers Squibb Company: | |||
| Basic | 5.35 | 2.64 | 1.09 |
| Diluted | 5.34 | 2.62 | 1.09 |
| Dividends declared per common share | 1.25 | 1.24 | 1.15 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |